Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu ...

The company said, “We reported that, as of December 31, 2024, we had cash and cash equivalent current assets balance of approximately $3.96 ...

We recently published a list of 7 Best Nanotech Penny Stocks to Invest In. In this article, we are going to take a look at ...

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...

SHELTON, Conn. (AP) — SHELTON, Conn. (AP) — NanoViricides Inc. (NNVC) on Friday reported a loss of $2 million in its fiscal second quarter. On a per-share basis, the Shelton, Connecticut-based ...

SHELTON, CT / ACCESS Newswire / February 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") declared today that it is ready to fight the bird flu with its revolutionary broad ...